drugset / Trial / NCT02232607
Efficacy and Safety of Lacidipine in Chronic Stable Angina
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study was to explore whether lacidipine at doses of 2 mg, 4 mg and 6 mg decreased the symptoms of angina, compared to placebo in patients with chronic stable angina
Timeline
- Start
- 1998-04
- Primary completion
- 1999-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacidipine | Small molecule | 2 mg | — |
| Subject | Lacidipine | Small molecule | 4 mg | — |
| Subject | Lacidipine | Small molecule | 6 mg | — |
Indications
No indication recorded.